This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
Addgene
product type :
cDNA
product name :
pVSV eGFP dG
catalog :
31842
citations: 24
Reference
Cousins H, Kline A, Wang C, Qu Y, Zengel J, Carette J, et al. Integrative analysis of functional genomic screening and clinical data identifies a protective role for spironolactone in severe COVID-19. Cell Rep Methods. 2023;3:100503 pubmed publisher
Li M, Du J, Liu W, Li Z, Lv F, Hu C, et al. Comparative susceptibility of SARS-CoV-2, SARS-CoV, and MERS-CoV across mammals. ISME J. 2023;17:549-560 pubmed publisher
Hou Y, Liu Y, Jia X, Zhou M, Mao W, Dong S, et al. Screening and Identification of Lassa Virus Entry Inhibitors from a Fragment-Based Drug Discovery Library. Viruses. 2022;14: pubmed publisher
Deng T, Li T, Chen G, Zhu Y, Xu L, Lin Y, et al. Characterization and immunogenicity of SARS-CoV-2 spike proteins with varied glycosylation. Vaccine. 2022;40:6839-6848 pubmed publisher
Wang S, Wu D, Xiong H, Wang J, Tang Z, Chen Z, et al. Potential of conserved antigenic sites in development of universal SARS-like coronavirus vaccines. Front Immunol. 2022;13:952650 pubmed publisher
Kazemi S, L xf3 pez Mu xf1 oz A, Holl xfd J, Jin L, Yewdell J, Dolan B. Variations in Cell Surface ACE2 Levels Alter Direct Binding of SARS-CoV-2 Spike Protein and Viral Infectivity: Implications for Measuring Spike Protein Interactions with Animal ACE2 Orthologs. J Virol. 2022;96:e0025622 pubmed publisher
Xiong H, Sun H, Wang S, Yuan L, Liu L, Zhu Y, et al. The neutralizing breadth of antibodies targeting diverse conserved epitopes between SARS-CoV and SARS-CoV-2. Proc Natl Acad Sci U S A. 2022;119:e2204256119 pubmed publisher
Biering S, Sarnik S, Wang E, Zengel J, Leist S, Sch xe4 fer A, et al. Genome-wide bidirectional CRISPR screens identify mucins as host factors modulating SARS-CoV-2 infection. Nat Genet. 2022;54:1078-1089 pubmed publisher
Wang Z, Xiang L, Lin F, Cai Z, Ruan H, Wang J, et al. Inhaled ACE2-engineered microfluidic microsphere for intratracheal neutralization of COVID-19 and calming of the cytokine storm. Matter. 2022;5:336-362 pubmed publisher
Cao J, Dong S, Liu Y, Zhou M, Guo J, Jia X, et al. Screening and Identification of Lujo Virus Entry Inhibitors From an Food and Drug Administration-Approved Drugs Library. Front Microbiol. 2021;12:793519 pubmed publisher
Kazemi S, López Muñoz A, Hollý J, Jin L, Yewdell J, Dolan B. Variations in cell-surface ACE2 levels alter direct binding of SARS-CoV-2 Spike protein and viral infectivity: Implications for measuring Spike protein interactions with animal ACE2 orthologs. bioRxiv. 2021;: pubmed publisher
Hennrich A, Sawatsky B, Santos Mandujano R, Banda D, Oberhuber M, Schopf A, et al. Safe and effective two-in-one replicon-and-VLP minispike vaccine for COVID-19: Protection of mice after a single immunization. PLoS Pathog. 2021;17:e1009064 pubmed publisher
Addetia A, Lieberman N, Phung Q, Hsiang T, Xie H, Roychoudhury P, et al. SARS-CoV-2 ORF6 Disrupts Bidirectional Nucleocytoplasmic Transport through Interactions with Rae1 and Nup98. MBio. 2021;12: pubmed publisher
Liu Y, Guo J, Cao J, Zhang G, Jia X, Wang P, et al. Screening of Botanical Drugs against Lassa Virus Entry. J Virol. 2021;: pubmed publisher
Koenig P, Das H, Liu H, Kummerer B, Gohr F, Jenster L, et al. Structure-guided multivalent nanobodies block SARS-CoV-2 infection and suppress mutational escape. Science. 2021;: pubmed publisher
Mykytyn A, Breugem T, Riesebosch S, Schipper D, van den Doel P, Rottier R, et al. SARS-CoV-2 entry into human airway organoids is serine protease-mediated and facilitated by the multibasic cleavage site. elife. 2021;10: pubmed publisher
Farzani T, Chov A, Herschhorn A. A protocol for displaying viral envelope glycoproteins on the surface of vesicular stomatitis viruses. STAR Protoc. 2020;1:100209 pubmed publisher
Mykytyn A, Lamers M, Okba N, Breugem T, Schipper D, van den Doel P, et al. Susceptibility of rabbits to SARS-CoV-2. Emerg Microbes Infect. 2021;10:1-7 pubmed publisher
Wang R, Simoneau C, Kulsuptrakul J, Bouhaddou M, Travisano K, Hayashi J, et al. Genetic Screens Identify Host Factors for SARS-CoV-2 and Common Cold Coronaviruses. Cell. 2021;184:106-119.e14 pubmed publisher
Wang S, Li W, Hui H, Tiwari S, Zhang Q, Croker B, et al. Cholesterol 25-Hydroxylase inhibits SARS-CoV-2 and other coronaviruses by depleting membrane cholesterol. EMBO J. 2020;39:e106057 pubmed publisher
Xiong H, Wu Y, Cao J, Yang R, Liu Y, Ma J, et al. Robust neutralization assay based on SARS-CoV-2 S-protein-bearing vesicular stomatitis virus (VSV) pseudovirus and ACE2-overexpressing BHK21 cells. Emerg Microbes Infect. 2020;9:2105-2113 pubmed publisher
Takahashi K, Yokobayashi Y. Reversible Gene Regulation in Mammalian Cells Using Riboswitch-Engineered Vesicular Stomatitis Virus Vector. ACS Synth Biol. 2019;8:1976-1982 pubmed publisher
Wang P, Liu Y, Zhang G, Wang S, Guo J, Cao J, et al. Screening and Identification of Lassa Virus Entry Inhibitors from an FDA-Approved Drug Library. J Virol. 2018;92: pubmed publisher
BEIER K, Saunders A, Oldenburg I, Miyamichi K, Akhtar N, Luo L, et al. Anterograde or retrograde transsynaptic labeling of CNS neurons with vesicular stomatitis virus vectors. Proc Natl Acad Sci U S A. 2011;108:15414-9 pubmed publisher
product information
Catalog Number :
31842
Product Name :
pVSV eGFP dG
article :
doi10.1073/pnas.1110854108
id5293
pubmed_id21825165
bacterial resistance :
Ampicillin
cloning :
backbonepBR322
backbone_mutation
backbone_origin
backbone_size
promoter
sequencing_primer_3
sequencing_primer_5
vector_types
Bacterial Expression
growth notes :
This plasmid could potentially be used to generate BL2 virus. It is the responsibility of the recipient scientist to ensure that they are in compliance with their institutions biosafety requirements.
origin :
30
pi :
alt_names
cloning
entrez_gene
genbank_ids
mutation
nameVSV genome
shRNA_sequence
size
species
tags
resistance markers :
71
tags :
High Copy
company information
Addgene
490 Arsenal Way, Suite 100
Watertown, MA 02472
info@addgene.org
https://www.addgene.org
617.225.9000
headquarters: USA